ES2038716T3 - Metodos y composiciones para el tratamiento de la psoriasis. - Google Patents

Metodos y composiciones para el tratamiento de la psoriasis.

Info

Publication number
ES2038716T3
ES2038716T3 ES88109039T ES88109039T ES2038716T3 ES 2038716 T3 ES2038716 T3 ES 2038716T3 ES 88109039 T ES88109039 T ES 88109039T ES 88109039 T ES88109039 T ES 88109039T ES 2038716 T3 ES2038716 T3 ES 2038716T3
Authority
ES
Spain
Prior art keywords
compositions
acidotimidine
psoriasis
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88109039T
Other languages
English (en)
Inventor
Madeleine Duvic
Gary W Brewton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The University of Texas System
The University of Texas at Austin
Original Assignee
The University of Texas System
The University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University of Texas System, The University of Texas at Austin filed Critical The University of Texas System
Application granted granted Critical
Publication of ES2038716T3 publication Critical patent/ES2038716T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

DESCUBIERTO SON METODOS Y COMPOSICIONES QUE EMPLEAN ACIDOTIMIDINA PARA EL TRATAMIENTO DE PSORIASIS. DOSIFICACION ORAL, PARENTERAL O TOPICA SON ADMINISTRADAS PARA AFECTAR A INDIVIDUOS EN CANTIDADES EFECTIVAS TERAPEUTICAMENTE. TIPICAMENTE, ENTRE 100 Y 4000 MG APROXIMADAMENTE DE ACIDOTIMIDINA ES ADMINISTRADO ORALMENTE POR DIA HASTA QUE LOS SINTOMAS DE LA ENFERMEDAD TALES COMO INFLAMACION, IRRITACION O INCIDENCIA O EL TAMAÑO DE LAS LESIONES, SON ABATIDAS. TAMBIEN DESCUBIERTO SON DOSIFICACIONES TOPICAS, QUE INCLUYEN FARMACEUTICAMENTE ACEPTABLES OREMAS, POMADAS, BALSAMOS Y QUE INCLUYE CONCENTRACIONES EFECTIVAS TERAPEUTICAMENTE DE ACIDOTIMIDINA. TALES COMPOSICIONES TOPICAS DEBEN ADEMAS INCLUIR CANTIDADES EFECTIVAS DE UN CORTICOSTEROIDE O UN AGENTE ANTI-PSIORATICO QUE ACTUA EN SUPERFICIES CUTANEAS, TALES COMO UN AGENTE KERATOLITICO.
ES88109039T 1987-06-09 1988-06-07 Metodos y composiciones para el tratamiento de la psoriasis. Expired - Lifetime ES2038716T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,907 US4804651A (en) 1987-06-09 1987-06-09 Methods and compositions for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
ES2038716T3 true ES2038716T3 (es) 1995-04-01

Family

ID=22026060

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88109039T Expired - Lifetime ES2038716T3 (es) 1987-06-09 1988-06-07 Metodos y composiciones para el tratamiento de la psoriasis.

Country Status (15)

Country Link
US (1) US4804651A (es)
EP (1) EP0301206B1 (es)
JP (1) JP2510675B2 (es)
KR (1) KR950014447B1 (es)
AT (1) ATE71301T1 (es)
AU (1) AU606423B2 (es)
DE (1) DE3867560D1 (es)
DK (1) DK310188A (es)
ES (1) ES2038716T3 (es)
GR (1) GR3003785T3 (es)
HU (1) HU200693B (es)
IE (1) IE61091B1 (es)
MY (1) MY103734A (es)
PH (1) PH26517A (es)
ZA (1) ZA884056B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
ATE168698T1 (de) * 1988-05-27 1998-08-15 Us Health Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
JP2831030B2 (ja) * 1989-05-12 1998-12-02 学校法人城西大学 ３’‐アジド‐３’デオキシチミジンを有効成分とする経皮投与製剤用組成物
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
US5162361A (en) * 1990-04-10 1992-11-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Method of treating diseases associated with elevated levels of interleukin 1
DK0663831T3 (da) * 1991-12-13 1995-07-26 Searle & Co Transdermal azidothymidin
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US5973010A (en) * 1998-05-15 1999-10-26 Crawford; Robert L. Composition for healing skin wounds
GR1003491B (el) * 1999-12-21 2000-11-30 Μεθοδος παρασκευης φαρμακοτεχνικου σκευασματος, αλοιφης η κρεμασκαι χρηση του στην αντιμετωπιση και θεραπεια της ψωριασεως και του εκζεματος
EP1998788A4 (en) * 2006-03-01 2011-08-03 Ruey J Yu COMPOSITIONS AND METHODS FOR THE TOPIC TREATMENT OF DERMATOLOGICAL DISORDERS RESPONSIBLE FOR TAR

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE73219B1 (en) * 1985-03-16 1997-05-07 Wellcome Found Therapeutic nucleosides
AU601556B2 (en) * 1987-03-16 1990-09-13 Wellcome Foundation Limited, The Therapeutic nucleosides

Also Published As

Publication number Publication date
DK310188D0 (da) 1988-06-08
GR3003785T3 (es) 1993-03-16
DK310188A (da) 1988-12-12
PH26517A (en) 1992-08-07
AU606423B2 (en) 1991-02-07
US4804651A (en) 1989-02-14
JP2510675B2 (ja) 1996-06-26
IE881708L (en) 1988-12-09
MY103734A (en) 1993-09-30
IE61091B1 (en) 1994-09-21
EP0301206B1 (en) 1992-01-08
DE3867560D1 (de) 1992-02-20
EP0301206A2 (en) 1989-02-01
KR890000093A (ko) 1989-03-11
EP0301206A3 (en) 1989-09-06
ZA884056B (en) 1989-06-28
KR950014447B1 (ko) 1995-11-28
AU1751088A (en) 1988-12-15
HU200693B (en) 1990-08-28
HUT47853A (en) 1989-04-28
JPS6470417A (en) 1989-03-15
ATE71301T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
ES2109899T1 (es) Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos.
ES2164097T3 (es) Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial.
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
CZ20023854A3 (cs) Topická kompozice pro léčbu psoriázy a příbuzných kožních onemocnění
FR2364030A1 (fr) Compositions pharmaceutiques a base d'anthocyanidines et procede pour leur preparation
US4256763A (en) Treatment of herpes simplex infections and acne
LU88684I2 (fr) Complexe lipidique d'amphotericine b ainsi que leurs dérivés pharmaceutiquement acceptables (abelcet )
MX173567B (es) Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih
ES2126123T3 (es) Empleo de cineol o mentol para el tratamiento de asma.
IT1255723B (it) Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
KR910005858A (ko) 지방산 요법
Mahrle et al. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate: comparative study of 113 patients
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
KR890000093A (ko) 건선의 치료방법 및 치료용 조성물
ES2115571T3 (es) Uso de polisulfato de pentosana para la resolucion de cicatrices en enfermedades vasculares progresivas cronicas.
PE12098A1 (es) Composiciones y metodos para tratar transtornos respiratorios
BR0008054A (pt) Forma cristalina de eplerenona
BR0313224A (pt) Composição farmacêutica contendo composto para terapia da disfunção sexual para ser administrada de modo oral que proporciona rápido inìcio de seus efeitos farmacológicos
Hillström et al. Comparison of ornidazole and tinidazole in single-dose treatment of trichomoniasis in women.
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
Kaufman Facial dermatitis of unknown cause
MX9306005A (es) Combinaciones de ibupropeno-cafeina.
BE894860A (fr) Therapeutique adjuvante par agent progestatif
Van der Rhee et al. Treatment of psoriasis vulgaris with a low-dosage Ro 10-9359 (Tigason) orally combined with corticosteroids topically

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301206

Country of ref document: ES